News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
148,857 Results
Type
Article (8246)
Company Profile (43)
Press Release (140568)
Section
Business (45542)
Career Advice (140)
Deals (8000)
Drug Delivery (30)
Drug Development (20691)
Employer Resources (12)
FDA (4357)
Job Trends (2701)
News (80208)
Policy (8934)
Tag
Academia (496)
Allergies (22)
Alliances (15571)
Alzheimer's disease (312)
Antibody-drug conjugate (ADC) (25)
Approvals (4343)
Artificial intelligence (26)
Bankruptcy (27)
Best Places to Work (2168)
Biosimilars (55)
Biotechnology (34)
Breast cancer (28)
Cancer (306)
Career advice (122)
Cell therapy (58)
Clinical research (16723)
Collaboration (117)
Compensation (19)
COVID-19 (653)
C-suite (30)
Data (312)
Diabetes (27)
Diagnostics (1050)
Drug discovery (18)
Earnings (15422)
Events (17298)
Executive appointments (68)
FDA (4549)
Funding (87)
Gene therapy (57)
GLP-1 (121)
Government (1431)
Healthcare (2873)
Immunology and inflammation (19)
Infectious disease (674)
Inflammatory bowel disease (47)
IPO (3171)
Job creations (603)
Job search strategy (120)
Layoffs (52)
Legal (1435)
Liver cancer (25)
Lung cancer (65)
Manufacturing (76)
Medical device (2163)
Medtech (2165)
Mergers & acquisitions (4902)
Metabolic disorders (65)
Neuroscience (374)
NextGen Class of 2024 (896)
Non-profit (407)
Northern California (337)
Obesity (24)
Opinion (39)
Patents (23)
Peanut (18)
People (11962)
Phase I (5158)
Phase II (6998)
Phase III (6135)
Pipeline (166)
Policy (27)
Postmarket research (510)
Preclinical (1975)
Press Release (66)
Radiopharmaceuticals (55)
Rare diseases (51)
Real estate (1400)
Regulatory (6554)
Research institute (459)
Southern California (352)
Startups (926)
United States (3052)
Vaccines (150)
Date
Today (30)
Last 7 days (188)
Last 30 days (930)
Last 365 days (9029)
2024 (8240)
2023 (9899)
2022 (14512)
2021 (14559)
2020 (13047)
2019 (9072)
2018 (7026)
2017 (8087)
2016 (7297)
2015 (8785)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (160)
Asia (24871)
Australia (3022)
California (790)
Canada (267)
China (142)
Colorado (28)
Europe (23711)
Florida (80)
Illinois (39)
Indiana (27)
Japan (34)
Maryland (269)
Massachusetts (535)
Minnesota (55)
New Jersey (354)
New York (232)
North Carolina (182)
Northern California (337)
Ohio (28)
Pennsylvania (145)
South America (225)
Southern California (352)
Texas (87)
Utah (18)
Washington State (58)
148,857 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Biotech Bay
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today issued the following statement about the closure of COBRA, a minimum residual disease (MRD) study.
September 1, 2023
·
3 min read
Drug Development
Biond Biologics Announces First Patient Dosed with BND-35 in Phase 1 Clinical Trial
Biond Biologics Ltd. today announced that the first patient has been dosed in a first-in-human clinical trial testing BND-35, a humanized ILT3/LILRB4 antagonist antibody.
June 24, 2024
·
4 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Press Releases
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
September 12, 2024
·
4 min read
Policy
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration has accepted Eisai’s Supplemental Biologics License Application for monthly lecanemab-irmb intravenous maintenance dosing.
June 9, 2024
·
19 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Press Releases
Biologics Market Size to Reach USD 699.5 Billion by 2032, Impelled by Emergence of Advanced Drug Delivery Systems
Biologics Market Outlook 2024-2032:
August 8, 2024
·
14 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses
This announcement summarizes Bioretec Ltd’s business review for January-March 2024.
May 16, 2024
·
6 min read
1 of 14,886
Next
